With regard to the P&G deal its initially a funding deal for the products. OBJ mention at the last dot point "Royalty payments payable to OBJ on further Licensed products"
Does that mean they wont be receiving any royalties for this current product deal ( 7 products) that they have entered into but any further products after these 7 then they will receive royalties?
Just a question as pharmaceutical license deals are not always straight forward.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable